Fusion glycoprotein F0产品信息
英文名称：Respiratory syncytial virus F protein
中文名称：呼吸道合胞病毒F蛋白
靶点别称：Fusion glycoprotein F0
物种：Mumps virus
属性：Protein
标记：Unconjugated
表达区间及表达系统（Source）
Mumps virus (strain Miyahara vaccine) (MuV) Fusion glycoprotein F0, His Tag (RSF-V52H4) is expressed from human 293 cells (HEK293). It contains AA Val 20 - ILe 486(FAGIAIGIA 103-111del) (Accession # P11236 (FAGIAIGIA 103-111del)).
Predicted N-terminus: Val 20
蛋白结构（Molecular Characterization）
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 51.9 kDa. The protein migrates as 53-63 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
内毒素（Endotoxin）
Less than 1.0 EU per μg by the LAL method.
纯度（Purity）
>90% as determined by SDS-PAGE.
制剂（Formulation）
Lyophilized from 0.22 μm filtered solution in PBS with trehalose as protectant.
Contact us for customized product form or formulation.
重构方法（Reconstitution）
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存储（Storage）
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
Fusion glycoprotein F0分子背景
Mumps immunity is typically assessed by measuring neutralizing-antibody responses directed against mumps HN and F proteins.
关键字： Fusion glycoprotein;F蛋白;HRSV F蛋白;ACRO;百普赛斯;
百普赛斯集团ACROBiosystems Group（股票代码：301080）是成立于2010年的跨国生物科技公司，是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球，横跨亚洲、北美洲、欧洲，在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家，与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。